Published in Nat Rev Drug Discov on October 16, 2009
Spiroindolones, a potent compound class for the treatment of malaria. Science (2010) 5.94
Chemical genetics of Plasmodium falciparum. Nature (2010) 5.52
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci U S A (2011) 3.23
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci U S A (2011) 2.83
Malaria medicines: a glass half full? Nat Rev Drug Discov (2015) 2.53
A transcriptional switch underlies commitment to sexual development in malaria parasites. Nature (2014) 2.44
The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med (2012) 2.42
The systematic functional analysis of Plasmodium protein kinases identifies essential regulators of mosquito transmission. Cell Host Microbe (2010) 2.13
Spiroindolone KAE609 for falciparum and vivax malaria. N Engl J Med (2014) 1.99
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J Med Chem (2011) 1.94
Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod (2010) 1.90
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Lancet Infect Dis (2015) 1.72
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis (2011) 1.68
PfCRT and its role in antimalarial drug resistance. Trends Parasitol (2012) 1.63
The global pipeline of new medicines for the control and elimination of malaria. Malar J (2012) 1.57
Drug discovery: Priming the antimalarial pipeline. Nature (2010) 1.40
Global phenotypic screening for antimalarials. Chem Biol (2012) 1.35
The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob Agents Chemother (2012) 1.35
Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique. PLoS One (2010) 1.33
Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening. Am J Trop Med Hyg (2012) 1.28
Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem (2011) 1.28
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc Natl Acad Sci U S A (2012) 1.26
Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics (2011) 1.17
The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya. Malar J (2013) 1.15
A call for using natural compounds in the development of new antimalarial treatments - an introduction. Malar J (2011) 1.14
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria. ACS Med Chem Lett (2011) 1.12
Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes. J Infect Dis (2011) 1.10
Control of malaria. Nat Rev Drug Discov (2010) 1.08
Titan cell production enhances the virulence of Cryptococcus neoformans. Infect Immun (2012) 1.07
Artemisone effective against murine cerebral malaria. Malar J (2010) 1.07
Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth. Antimicrob Agents Chemother (2010) 1.07
Drug discovery for neglected diseases: molecular target-based and phenotypic approaches. J Med Chem (2013) 1.05
Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum. Proc Natl Acad Sci U S A (2012) 1.04
Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination. PLoS Comput Biol (2014) 1.01
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase. Bioorg Med Chem Lett (2012) 1.00
In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrob Agents Chemother (2011) 0.99
The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives. Chem Rev (2013) 0.98
A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. J Med Chem (2011) 0.98
The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence. Malar J (2014) 0.96
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors. J Med Chem (2014) 0.96
Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum. Malar J (2013) 0.95
Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro. Stem Cell Reports (2015) 0.94
Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. J Chem Inf Model (2013) 0.93
Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis. ACS Med Chem Lett (2013) 0.91
A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery. PLoS One (2015) 0.91
Drugs for malaria: something old, something new, something borrowed. F1000 Biol Rep (2011) 0.91
Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter. Mol Microbiol (2015) 0.90
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax. Pathog Glob Health (2015) 0.90
Discovery of potent, novel, non-toxic anti-malarial compounds via quantum modelling, virtual screening and in vitro experimental validation. Malar J (2011) 0.90
Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria. Am J Trop Med Hyg (2011) 0.90
In vitro synergistic effect of fluoroquinolone analogues in combination with artemisinin against Plasmodium falciparum; their antiplasmodial action in rodent malaria model. Malar J (2015) 0.89
The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study. Malar J (2013) 0.88
Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls. Parasitology (2012) 0.87
Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination. Malar J (2015) 0.87
Determination of antiprotozoal drug mechanisms by metabolomics approaches. Parasitology (2013) 0.86
Plasmodium falciparum chloroquine resistance transporter is a H+-coupled polyspecific nutrient and drug exporter. Proc Natl Acad Sci U S A (2015) 0.86
Cyclopropyl Carboxamides: A New Oral Antimalarial Series Derived from the Tres Cantos Anti-Malarial Set (TCAMS). ACS Med Chem Lett (2011) 0.86
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens. Med Chem Res (2011) 0.85
Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis. Malar J (2013) 0.85
Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit. ACS Med Chem Lett (2014) 0.84
Relative to quinine and quinidine, their 9-epimers exhibit decreased cytostatic activity and altered heme binding but similar cytocidal activity versus Plasmodium falciparum. Antimicrob Agents Chemother (2012) 0.84
Repositioning: the fast track to new anti-malarial medicines? Malar J (2014) 0.83
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents. J Med Chem (2014) 0.83
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol (2016) 0.83
The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains. Chem Biol (2012) 0.83
Current status of the clinical development and implementation of paediatric artemisinin combination therapies in Sub-Saharan Africa. Wien Klin Wochenschr (2011) 0.83
Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy. Antimicrob Agents Chemother (2011) 0.81
Synthesis and preliminary biological evaluation of a small library of hybrid compounds based on Ugi isocyanide multicomponent reactions with a marine natural product scaffold. Bioorg Med Chem Lett (2015) 0.80
4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborni. Antimicrob Agents Chemother (2013) 0.80
Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors. Nanoscale Res Lett (2011) 0.79
Use of Broken-Symmetry Density Functional Theory To Characterize the IspH Oxidized State: Implications for IspH Mechanism and Inhibition. J Chem Theory Comput (2014) 0.79
Synthesis, Antiplasmodial Activity, and β-Hematin Inhibition of Hydroxypyridone-Chloroquine Hybrids. ACS Med Chem Lett (2013) 0.79
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model. Antimicrob Agents Chemother (2013) 0.79
Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges. Br J Clin Pharmacol (2015) 0.79
No evidence of decreased artemisinin efficacy in a high-transmission malaria setting in Mali. Am J Trop Med Hyg (2012) 0.78
Antimalarial drugs: Speeding to a new lead. Nat Rev Drug Discov (2010) 0.78
The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel. Malar J (2011) 0.78
Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron-Sulfur Enzyme in Pathogenic Bacteria. Inorg Chem (2015) 0.78
Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii. Infect Immun (2014) 0.78
4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity. J Med Chem (2013) 0.78
Design and Synthesis of Novel Hybrid Molecules against Malaria. Int J Med Chem (2015) 0.77
Antimalarial activity of cupredoxins: the interaction of Plasmodium merozoite surface protein 119 (MSP119) and rusticyanin. J Biol Chem (2013) 0.76
Utilizing a dynamical description of IspH to aid in the development of novel antimicrobial drugs. PLoS Comput Biol (2013) 0.76
Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi. Am J Trop Med Hyg (2015) 0.75
Synthesis and stereochemical determination of an antiparasitic pseudo-aminal type monoterpene indole alkaloid. J Nat Med (2016) 0.75
Discovery and optimisation studies of antimalarial phenotypic hits. Eur J Med Chem (2015) 0.75
Investigation of acyclic uridine amide and 5'-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase. Bioorg Med Chem (2013) 0.75
Antimalarial activity of fractions of aqueous extract of Acacia nilotica root. J Intercult Ethnopharmacol (2016) 0.75
A humanized mouse model for sequestration of Plasmodium falciparum sexual stages and in vivo evaluation of gametocytidal drugs. Sci Rep (2016) 0.75
Synthesis of a potent antimalarial agent through natural products conjugation. ChemMedChem (2013) 0.75
In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery. Chem Biol Drug Des (2014) 0.75
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms. Clin Pharmacol Ther (2016) 0.75
Towards a Humanized Mouse Model of Liver Stage Malaria Using Ectopic Artificial Livers. Sci Rep (2017) 0.75
Esterase mutation is a mechanism of resistance to antimalarial compounds. Nat Commun (2017) 0.75
In vivo anti-plasmodial activities and toxic impacts of lime extract of a combination of Picralima nitida, Alstonia boonei and Gongronema latifolium in mice infected with Chloroquine-sensitive Plasmodium berghei. Afr Health Sci (2015) 0.75
Mathematical Modelling to Guide Drug Development for Malaria Elimination. Trends Parasitol (2016) 0.75
Antimalarial activity of Syzygium guineense during early and established Plasmodium infection in rodent models. BMC Complement Altern Med (2017) 0.75
Antimalarial drugs: A treasure trove of potential antimalarials. Nat Rev Drug Discov (2010) 0.75
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med (2008) 17.65
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98
The economic burden of malaria. Am J Trop Med Hyg (2001) 11.14
Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis (2008) 9.87
A NATURALLY ACQUITED QUOTIDIAN-TYPE MALARIA IN MAN TRANSFERABLE TO MONKEYS. Science (1965) 6.49
Mixed-species malaria infections in humans. Trends Parasitol (2004) 6.01
Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature (2008) 5.96
Malaria. Did they really say ... eradication? Science (2007) 5.04
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A (2008) 4.80
Identification of an antimalarial synthetic trioxolane drug development candidate. Nature (2004) 4.57
Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci (1999) 4.52
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell (2007) 3.37
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev (1996) 3.26
Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol (2002) 2.91
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg (2007) 2.58
Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov (2008) 2.58
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol (2003) 2.32
A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science (2002) 2.27
Editorial: Global Health Fund or Global Fund to fight AIDS, Tuberculosis, and Malaria? Trop Med Int Health (2002) 2.25
The global portfolio of new antimalarial medicines under development. Clin Pharmacol Ther (2009) 2.16
Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis (2009) 2.15
Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J Med Chem (2009) 1.87
A pre-emptive strike against malaria's stealthy hepatic forms. Nat Rev Drug Discov (2009) 1.77
High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem (2005) 1.73
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One (2009) 1.64
Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One (2008) 1.61
Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health (2006) 1.56
The apicoplast: a review of the derived plastid of apicomplexan parasites. Curr Issues Mol Biol (2005) 1.54
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2002) 1.53
Cultivation of Plasmodium vivax. Trends Parasitol (2008) 1.50
A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis (2005) 1.49
First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg (1998) 1.48
Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. J Med Chem (2008) 1.43
Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J Med Chem (2009) 1.42
The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev (1987) 1.38
An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol Ther (1999) 1.38
Discovery of dual function acridones as a new antimalarial chemotype. Nature (2009) 1.36
Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note. Br Med J (1980) 1.34
Protein kinases of malaria parasites: an update. Trends Parasitol (2008) 1.29
Antimalarial drug resistance and the importance of drug quality monitoring. J Postgrad Med (2006) 1.22
Selection of a trioxaquine as an antimalarial drug candidate. Proc Natl Acad Sci U S A (2008) 1.18
Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure (2007) 1.10
X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy. J Biol Chem (2007) 1.07
A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother (2007) 1.07
Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity. J Med Chem (2009) 1.06
Folate metabolism as a source of molecular targets for antimalarials. Future Microbiol (2006) 1.01
Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. J Biol Chem (2008) 1.01
Transition states and inhibitors of the purine nucleoside phosphorylase family. Curr Top Med Chem (2005) 1.00
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivity. J Mol Biol (2008) 0.98
Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles. J Med Chem (2008) 0.87
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Malaria: progress, perils, and prospects for eradication. J Clin Invest (2008) 6.54
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis (2009) 5.90
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet (2007) 4.83
Mass treatment with single-dose azithromycin for yaws. N Engl J Med (2015) 3.84
Some lessons for the future from the Global Malaria Eradication Programme (1955-1969). PLoS Med (2011) 3.42
Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat Genet (2012) 2.86
Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J (2009) 2.83
Health and survival of young children in southern Tanzania. BMC Public Health (2008) 2.83
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis (2012) 2.53
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J Infect Dis (2009) 2.36
A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One (2008) 2.29
Concentration of DDT compounds in breast milk from African women (Manhiça, Mozambique) at the early stages of domestic indoor spraying with this insecticide. Chemosphere (2011) 2.01
Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow. Blood (2013) 2.01
An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases. PLoS Med (2008) 1.96
Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med (2007) 1.93
Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar J (2009) 1.87
A 10 year study of the cause of death in children under 15 years in Manhiça, Mozambique. BMC Public Health (2009) 1.76
Malaria in rural Mozambique. Part II: children admitted to hospital. Malar J (2008) 1.72
Malaria in rural Mozambique. Part I: children attending the outpatient clinic. Malar J (2008) 1.68
Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One (2010) 1.67
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials (2006) 1.65
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One (2009) 1.64
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2002) 1.60
Severe malaria and concomitant bacteraemia in children admitted to a rural Mozambican hospital. Trop Med Int Health (2009) 1.58
Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique. Am J Trop Med Hyg (2007) 1.57
Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatr Infect Dis J (2002) 1.56
Clinical malaria in African pregnant women. Malar J (2008) 1.54
Plasmodium falciparum multiple infections in Mozambique, its relation to other malariological indices and to prospective risk of malaria morbidity. Trop Med Int Health (2003) 1.53
Haematological and biochemical indices in young African children: in search of reference intervals. Trop Med Int Health (2006) 1.52
The epidemiology of malaria in adults in a rural area of southern Mozambique. Malar J (2007) 1.49
Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis (2011) 1.45
The severe gout of Holy Roman Emperor Charles V. N Engl J Med (2006) 1.43
Performance of HRP-2 based rapid diagnostic test for malaria and its variation with age in an area of intense malaria transmission in southern Tanzania. Malar J (2010) 1.37
Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop (2011) 1.36
Polarisation microscopy increases the sensitivity of hemozoin and Plasmodium detection in the histological assessment of placental malaria. Acta Trop (2004) 1.35
Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study. J Acquir Immune Defic Syndr (2010) 1.34
Health care seeking for childhood diarrhea in developing countries: evidence from seven sites in Africa and Asia. Am J Trop Med Hyg (2013) 1.34
Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health (2009) 1.33
Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique. PLoS One (2010) 1.33
Clinico-pathological discrepancies in the diagnosis of causes of maternal death in sub-Saharan Africa: retrospective analysis. PLoS Med (2009) 1.27
Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Malar J (2009) 1.26
Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus. Pediatr Infect Dis J (2011) 1.25
Seasonal variations in maternal mortality in Maputo, Mozambique: the role of malaria. Trop Med Int Health (2007) 1.24
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. J Infect Dis (2012) 1.23
Defying malaria: Fathoming severe Plasmodium vivax disease. Nat Med (2011) 1.18
How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma. Clin Infect Dis (2012) 1.15
Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique. Am J Trop Med Hyg (2010) 1.13
Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique. PLoS One (2011) 1.13
Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr (2009) 1.13
Distinguishing malaria from severe pneumonia among hospitalized children who fulfilled integrated management of childhood illness criteria for both diseases: a hospital-based study in Mozambique. Am J Trop Med Hyg (2011) 1.12
The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J Infect Dis (2010) 1.12
Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique. Infect Immun (2009) 1.11
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence. Expert Opin Pharmacother (2012) 1.10
Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am J Trop Med Hyg (2009) 1.09
Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications. Malar J (2007) 1.09
Determinants of household demand for bed nets in a rural area of southern Mozambique. Malar J (2009) 1.08
Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. Vaccine (2011) 1.07
Relationship between haemoglobin and haematocrit in the definition of anaemia. Trop Med Int Health (2006) 1.06
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial. Vaccine (2007) 1.05
Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infect Dis Obstet Gynecol (2010) 1.03
Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor. PLoS One (2011) 1.03
HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. Clin Infect Dis (2011) 1.03
Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS One (2010) 1.02
Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study. Malar J (2012) 1.01
Plasmodium vivax malaria in Mali: a study from three different regions. Malar J (2012) 1.01
Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction. J Pediatr (2013) 1.01
Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting. Infect Immun (2009) 1.00
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. PLoS One (2012) 0.99
Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun (2012) 0.99
Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique. Antimicrob Agents Chemother (2009) 0.99
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial. PLoS One (2010) 0.99
Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique. J Med Virol (2002) 0.99
Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique. Clin Vaccine Immunol (2008) 0.98
Breast milk and gut microbiota in African mothers and infants from an area of high HIV prevalence. PLoS One (2013) 0.95
Integrated vector management targeting Anopheles darlingi populations decreases malaria incidence in an unstable transmission area, in the rural Brazilian Amazon. Malar J (2012) 0.95
The effects of short-term iron supplementation on iron status in infants in malaria-endemic areas. Am J Trop Med Hyg (2004) 0.94
Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Infect Immun (2011) 0.93
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin Vaccine Immunol (2011) 0.93
A direct comparison of real time PCR on plasma and blood to detect Plasmodium falciparum infection in children. Malar J (2012) 0.92
Towards an effective malaria vaccine. Arch Dis Child (2007) 0.92
Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. J Infect Dis (2013) 0.91
Assessment of the epidemiology and burden of measles in Southern Mozambique. Am J Trop Med Hyg (2011) 0.90
Incidence of Tuberculosis Among Young Children in Rural Mozambique. Pediatr Infect Dis J (2015) 0.88
Invasive Haemophilus influenzae disease in children less than 5 years of age in Manhiça, a rural area of southern Mozambique. Trop Med Int Health (2008) 0.88
Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology. Malar J (2011) 0.87
Viral acute respiratory infections among infants visited in a rural hospital of southern Mozambique. Trop Med Int Health (2011) 0.86
Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery. Infect Immun (2010) 0.86
Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens. PLoS One (2011) 0.85
High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLoS One (2013) 0.84
Antibody response after RSV infection in children younger than 1 year of age living in a rural area of Mozambique. J Med Virol (2003) 0.84
Drug exposure and pregnancy outcome in Mozambique. Paediatr Drugs (2012) 0.84
Severity of anaemia is associated with bone marrow haemozoin in children exposed to Plasmodium falciparum. Br J Haematol (2014) 0.84
Detection of Salmonella enterica serotype typhimurium DT104 in Mozambique. Am J Trop Med Hyg (2008) 0.84
Transcription of var genes other than var2csa in Plasmodium falciparum parasites infecting Mozambican pregnant women. J Infect Dis (2011) 0.84
Challenges in the diagnosis of iron deficiency in children exposed to high prevalence of infections. PLoS One (2012) 0.83
Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique. Pediatr Infect Dis J (2007) 0.83